CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 142 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,205,365 | +1377.5% | 566,700 | +392.7% | 1.48% | +1802.6% |
| Q3 2021 | $420,000 | -41.4% | 115,015 | -17.8% | 0.08% | -69.9% |
| Q3 2019 | $717,000 | -90.2% | 140,000 | -74.5% | 0.26% | -87.2% |
| Q1 2019 | $7,304,000 | +28.0% | 550,000 | -24.1% | 2.02% | -5.0% |
| Q4 2018 | $5,705,000 | -26.2% | 725,000 | +3.9% | 2.13% | +8.2% |
| Q3 2018 | $7,735,000 | -17.4% | 698,100 | +0.1% | 1.97% | -18.8% |
| Q2 2018 | $9,360,000 | +8.4% | 697,500 | +4.9% | 2.42% | -1.9% |
| Q1 2018 | $8,638,000 | +41.2% | 665,000 | 0.0% | 2.47% | +26.1% |
| Q4 2017 | $6,118,000 | +14.2% | 665,000 | 0.0% | 1.96% | +3.4% |
| Q3 2017 | $5,356,000 | – | 665,000 | – | 1.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,023,369 | $27,154,000 | 9.26% |
| Omega Fund Management, LLC | 551,477 | $7,401,000 | 5.46% |
| Foresite Capital Management III, LLC | 1,562,040 | $20,963,000 | 4.51% |
| Versant Venture Management, LLC | 1,048,601 | $14,072,225,000 | 4.39% |
| Boxer Capital, LLC | 2,094,000 | $28,101,000 | 3.18% |
| Opaleye Management Inc. | 697,500 | $9,360,000 | 2.42% |
| Abingworth LLP | 273,417 | $3,667,000 | 2.10% |
| DAFNA Capital Management LLC | 294,511 | $3,952,000 | 1.85% |
| NEXTHERA CAPITAL LP | 828,655 | $11,121,000 | 1.72% |
| Vivo Capital, LLC | 906,000 | $12,158,000 | 1.57% |